We show that recombinant rat glucocorticoid receptor (vvGR) expressed using vaccinia virus is Indistinguishable from authentic GR with respect to DNA and hormone binding. In the absence of hormone, wGR is mainly found In the cytoplasm in a complex with heat shock protein 90. Upon Incubation with ligand, wGR Is released from this complex and translocated to the nucleus. Thus, the ligand binding domain displays the known biochemical properties. However, In vitro, transcription from a synthetic promoter and from the mouse mammary tumor virus (MMTV) promoter Is enhanced by recombinant GR In a ligand independent manner. Both transactivatlon domains contribute to the transcriptional activity, addltively on a synthetic promoter and cooperatively on the MMTV promoter. We thus provide the first evidence that In vitro the hormone binding domain has a transcriptional activity even in the absence of ligand.
INTRODUCTION
Glucocorticoid receptor (GR) is a ligand inducible transcription factor that belongs to the superfamily of nuclear receptors (for reviews see 1, 2) . GR, like the receptors for progesterone (PR), mineralocorticoid (MR), androgen (AR) and estrogen (ER) hormones, belongs to the steroid receptor subfamily, hereafter referred to as type I receptors (3) . Type I receptors are structurally and functionally related and specific properties can be assigned to distinct domains (4, 5) . Transcriptional activation is mediated through binding of the receptor to hormone response elements (HREs) that are located within enhancers or in the promoter regions of responsive genes (1) . The semi-palindromic structure of the HRE dictates the binding of type I receptors as homodimers (6, 7) . The amino-tenninal AB-domain contains a so-called constitutive activation function (AF1) that is active in the absence of hormone (4, 5, 8) . The central C-domain is composed of two zinc fingers that are involved in DNA binding and dimerization (6, 9, 10) .
Multiple functions have been assigned to the carboxy-terminal EF-domain that binds hormone. Unliganded GR, unlike other type I receptors, resides in the cytoplasm (11) in a multiprotein complex including heat shock protein 90 (HSP90) and p59 (12, 13) . Interactions between GR and HSP90 involve amino acids in the E region of the receptor (14) . The importance of this interaction with respect to transcriptional activation by GR is suggested from experiments performed in yeast where a reduced level of HSP90 compromised the activity of the receptor (15) . Upon binding of hormone, GR is released from the HSP90 containing complex and translocated to the nucleus (11, 16) . The EF-domain contains another dimerization interface and a liganddependent transactivation function (termed AF2) (4, 5) . Mutations within the hormone binding domain affecting transactivation but not ligand-and DNA binding properties of mouse ER as well as GR have been described (17) . Transfection experiments have shown that the constitutive AB-and the hormone inducible EFdomains functionally cooperate in transactivation in a promoterand cell-type specific manner but the determinants for this specificity are not well understood (4, 5, 18, 19) . Synergistic transactivation through both domains has been detected on natural promoters such as the mouse mammary tumor virus (MMTV) promoter and could be mediated by the interaction of GR with other transcription factors (for review, see 20) .
The requirement for hormone in transactivation is suggested from experiments using the antiglucocorticoid RU 486 (for review, see 21) . This antagonist triggers the dissociation of the receptor-HSP90 complex and induces the translocation of GR to the nucleus (11) . Antagonist loaded receptor can bind to its cognate response element but it has only weak transactivation properties probably mediated through the AB-domain only (4, 5, 22) . Ligand binding thus appears to be essential for two steps in the pathway leading to a transcriptionally active receptor. Firstly, it is required for dissociation of GR from the cytoplasmic HSP90 containing complex allowing its translocation to the nucleus. Secondly, it modulates the activity of the liganddependent transactivation domain in vivo. A conformational change is believed to occur in the hormone binding domain of
• To whom correspondence should be addressed type I receptors upon binding of ligand (23, 24) . PR and ER require ligand to bind DNA in vitro whereas GR can bind DNA in vitro in the absence of hormone (25, 26) . Reconstituted cellfree transcription experiments using PR provided ambiguous results concerning the requirements for hormone (27) (28) (29) (30) . In vitro studies using baculovirus expressed recombinant GR showed that the ligand does not affect its transactivation properties (31) . At present, the molecular basis for a requirement of hormone in transcriptional activation by GR remains poorly understood. It is not clear whether the presence of bound hormone is required for transcriptional activity of the hormone binding domain.
The contribution of the hormone binding domain to the overall transcriptional activity of GR in vitro and the role of the ligand in governing the activity of this domain were analyzed. We established a cell-free transcription system based on HeLa nuclear extracts and recombinant GR. The integrity of the recombinant proteins was tested biochemically with respect to HSP90 complexation, ligand and DNA binding. Truncated receptors, as well as a double point mutant in the 'ligand dependent' transactivation domain, were used to determine the transcriptional activity of the AB-and EF-domains on two different responsive promoters in vitro.
MATERIALS AND METHODS

Cells and vaccinia recombinant viruses
The first nucleotides of the rat GR cDNA were modified in order to create a Xho I site. The resulting cDNA was cloned as a Xho I-Xba I 2.8 kb fragment into pMS56 (32) . The foreign amino acids added to the N-terminus of H6GR were MSHHHHHHG-EFPGELDIAKGTSR preceding the second amino acid of rat GR. H6GRAAB was cloned as a Hpa n-Xba 11.5 kb fragment into pMS56. The N-terminal amino acids MSHHHHHHGEFPGEV-EEA precede amino acid number 406 of rat GR. H6GRAEF was constructed from H6GR replacing the C-terminal fragment from amino acid 524 (Pst I site in the cDNA) by the following aminoacids: TGIL. To construct H6GRmut, we prepared by polymerase chain reaction (PCR) an Eco RI fragment containing 157 nucleotides of the 3'-end from the mutated mouse receptor M758A/L759A (17) . The equivalent sequence of the rat cDNA was replaced by this fragment. Vaccinia recombinant viruses were prepared as described (32) and amplified in HeLa S3 cells grown in Joklik medium supplemented with 5 % new born calf serum. . The G-less cassette was shortened from 380 nucleotides to approximately 260 nucleotides by Bal 31 deletion from its 3' end and religation with a Not I linker. pML50 [180] was obtained from R. Cortese (34) . p4GRE.ML [320] was constructed by inserting 4 TAT-GREs (from position -2515/-2489 of the tyrosine amino transferase gene (35) upstream of the adenovirus major late TATA box. This construct was derived from pS-TI(C2AT) which contains the major late initiator and TATA elements and was obtained from R. Tjian (36) .
Transcription templates
Protein extraction and purification
HeLa S3 cells were grown at a density of 5.1O 5 cells/ml, washed with PBS and infected with recombinant vaccinia virus at a multiplicity of infection of 5 for 1 hour at room temperature. The infected cells were further incubated in serum free medium at a density of 10 6 cells/ml for 12 hours at 37°C. All subsequent steps were performed at 0°C. Receptors from cells incubated in the absence of hormone were prepared from cytoplasmic extracts in 20 mM Hepes pH 7.9, 5 mM MgCl 2 . 10 mM NaCl, 0.1 mM EDTA, 1 mM DTT, 10 mM NaF and 0.1 mM PMSF. After centrifugation (10,000 g -15 min.), the hormone was added to the crude cytoplasmic extract at a concentration of 100 nM. For purification, 1 ml Ni 2+ -NTA agarose (Qiagen) was added to the extract from 10 liters of cells and incubated on a rotating wheel for 1 hour. The resin was packed into a column and washed at 0.2 ml/min with 5 column volumes of buffer D300 (20 mM Hepes pH7.9, 5 mM MgCl 2 , 0.1 mM EDTA, 1 mM DTT, 10 mM NaF, 15% glycerol and 300 mM NaCl). The resin was further washed with 3 column volumes of buffer D100 (as buffer D3O0 but 100 mM NaCl) followed by a second wash with 3 column volumes of D100 containing 20 mM imidazole. The histidine tagged receptors were eluted in several fractions of 1 column volume with D100 containing 100 mM imidazole and 1 mg/ml cytochrome C. The receptor was detected in the eluate by counting bound [ To load the ligand in vivo, the hormone was added at a concentration of 100 nM in the culture medium during the last hour of infection. Cells were concentrated to 5.10 6 cells/ml and labeled hormone was diluted (with cold TA, to yield 5 CiAnmole). Receptors from hormone treated cells were purified from nuclear extracts prepared as described by Dignam et al. (37) . The receptors were purified over Ni 2+ -NTA columns as described above. Small scale whole cell extracts (WCE) were prepared by lysing the cells in 50 mM Tris-Cl pH 7.8, 420 mM NaCl, 5 mM MgCl 2 and 0.5% (v/v) Triton X-100. For storage, all crude extracts and NTA purified receptors were quick-frozen in liquid nitrogen and stored at -80°C. They were thawed only once just before use.
In vitro transcription
Transcription assays contained (30/d final volume): 20 mM Hepes pH7.9, 6 mM MgCl 2 , 60 mM NaCl, 0.2 mM EDTA, 1 mM DTT, 7.5% glycerol, 2.5% PEG 8000, 10 mM creatine phosphate, 1 /ig calf thymus DNA, 10 units RNase Tl (Sigma), 25 ng of each template (approximately 10 finoles), 0.6 mM ATP, 0.6 mM CTP, 20 (M UTP, 0.5 mM 3'-O methyl GTP (Pharmacia) and 0.4 /tM [alpha 32 ?] UTP (800 Ci/mmoles; Amersham). The HeLa nuclear transcription extract was prepared according to Dignam et al. (37) and the protein concentration was adjusted to approximately 5 mg/ml (15 to 20 /ig were used per reaction). Reaction mixtures were preincubated at 30°C with die receptor preparation and HeLa nuclear extract for 20 min in the absence of nucleotides. Transcription was initiated by the addition of nucleotides and the samples were incubated for 1 hour at 30°C. Reactions were terminated by addition of 180 /A stop mix (0.1 M NaAc pH 5.2, 10 mM EDTA, 0.1 % SDS, 20 |tg/ml tRNA) containing approximately 500 cpm of a 500 bp labeled DNA fragment, followed by phenol-chloroform-isoamyl alcohol (25:25:1) extraction. Autoradiography of the dried gels was performed at -80°C with an intensifying screen for 12 to 48 hours.
Gel retardation assay and oligonucleotides
The following synthetic oligonucleotide 5'-GATCCATCGTA-GCTAGAACAGACTGTTCTCGA-3' and hs complement, were annealed to obtain a double stranded template and labeled by filling in with [alpha^PJdATP and Klenow DNA polymerase. Crude extracts or NTA purified receptors were incubated for 15 min on ice in a binding buffer containing 20 mM Hepes pH 7.9, 5 mM MgCl 2 , 60 mM NaCl, 15% glycerol, 0.1% Triton X-100 and 50 /tg/ml poly(dI-dC). Subsequently 5-40 fmoles of oligonucleotide probe was added and the reaction was continued for 15 min. The complexes formed were separated on 4% polyacrylamide gels (reticulation: 39/1), containing 0.1 % Triton X-100, run at 10 volts/cm in 0.25 xTBE at 4°C. Subsequently the gels were dried and exposed for autoradiography. As competitor oligonuceotides, we used the palindromic GRE described previously or the following blunted/double stranded vitamin D3 response element: 5'-TCTAGGTGACTC-ACCGGGTGAACGGG-3'.
Western blotting, immunofluorescence and antibodies
Proteins were analyzed on SDS -PAGE and immunoblotted using alkaline phosphatase coupled secondary antibodies as described (38) . The monoclonal antibody directed against the GR-DNA binding domain was kindly provided by A.C.Wikstrom (unpublished). The polyclonal aPl rabbit serum directed against the C-terminal part of rat GR was a generous gift from B.Groner (39) . The rabbit anti-HSP90 serum was obtained from B.Hoveman (unpublished). For intracellular localization of wGR, HeLa cells were grown on cover slips in serum free medium without phenol red. The cells were fixed with medianol 12 hours after infection and processed for immunofluorescent staining using rhodamine-coupled secondary antibodies according to standard procedures (38) . As first antibody, we used the polyclonal GR-IE rabbit antiserum diluted 1/200 (kindly provided by M.Alexis).
Hormone binding assay
Hormone binding in vitro was done in a batch assay using hydroxylapatite essentially as described (40) . Saturation curves were obtained by plotting specifically bound hormone corrected for protein concentration against the concentration of hormone added in the extract.
RESULTS
Rat GR was expressed in HeLa cells using the vaccinia virus system and was termed wGR (41) . In this study, receptors were N-terminally tagged with a stretch of six histidines (abbreviated H6) to facilitate rapid purification under native conditions by Ni 2+ -NTA affinity chromatography (32, 42) . A schematic representation of the recombinant receptors, called H6GR (full- Figure 2 . wGR is associated with HSP90 in cytoplasmic extracts. Cytoplasmk extracts from wGR infected cells prepared in the absence of hormone were incubated at 30°C in the absence (panel A) or in the presence (panel B) of 100 nM dexamethasooe. Subsequently, the extracts were loaded on a Mono-Q column (Pharmacia) equilibrated in a buffer containing 50 mM NaO and molybdate was washed out. The proteins retained on the column were ehited with an increasing salt gradient and aliquots of the fractions obtained were applied on SDS-PAGE. After blotting of the gels, GR and HSP90 were detected with the corresponding antibodies (aPl and anti-HSP90, respectively). Molecular weights (MW) of marker proteins are indicated in Idlodaltons on the left side of each panel.
length receptor), H6GRAAB (lacking the N-terminal AB domain), H6GRAEF (lacking the C-terminal EF domain but preserving the nuclear localization signal) and H6GRmut (bearing a double point mutation M770A/L771A), is shown in Fig. 3A .
IntraceUular localization of vaccinia virus expressed GR
The intracellular localization of vaccinia virus expressed GR was determined by immunocytochemistry. For this purpose, HeLa cells infected with recombinant vaccinia virus were incubated in the absence of serum and phenol red to avoid possible interference by components present in the medium. Under these conditions, wGR is predominantly localized within the cytoplasm of infected cells. Addition of dexamethasone results in translocation of the receptor to the nucleus in a dose-dependent manner ( Fig. 1A and B and data not shown). Similar results were obtained using either triamcinolone acetonide (TA) or the antagonist RU 486 (data not shown). Endogenous HeLa GR could not be detected either in mock or wild-type vaccinia virus (wWT) infected HeLa cells under the assay conditions (data not shown).
The results indicate that recombinant wGR is cytoplasmic in the absence of ligand and can be translocated to the nucleus in a hormone-dependent manner similar to authentic GR (11).
Vaccinia virus expressed GR binds hormone in vitro
Next, we determined the affinity of recombinant and endogenous human GR for radioactively labeled triamcinolone acetonide (TA) in vitro. ID) . As expected for a functional GR, the affinity is higher for RU 486 than for the agonists and wGR has no appreciable affinity for E? (43) . Thus vaccinia expressed GR binds glucocorticoids with similar affinity and specificity as endogenous GR.
Vaccinia virus expressed GR is associated with HSP90 in the cytoplasm
To determine whether recombinant GR is associated with endogenous HSP90, we made use of the observation that GR in a complex containing HSP90 is retained on a Mono Q column.
The complex elutes at around 300 mM NaCI whereas 'free' GR elutes at approximately 100 mM NaCI (16) . We used this assay in addition to a co-immunoprecipitation experiment (not shown) because it provides more information about the fraction of receptor which is complexed to HSP90. Cells infected with wGR were incubated in serum free medium, in the absence of hormone, and cytoplasmic extracts were prepared in low salt buffer containing molybdate to preserve a putative GR-HSP90 complex 6) . Recombinant glucocorticoid receptor (H6GR) was purified by Ni 2+ -NTA chromatography from nuclear extracts of cells incubated in die presence of hormone. We used 0.6 pmoles receptor in each reaction. For control experiments, we prepared an extract from wild type vaccinia virus infected cells (wWT) using the same procedure as for the H6GR extract. At die end of the transcription reaction, a labeled DNA fragment was added to control for recovery of die transcripts. Relative amounts of the transcripts were determined by scanning die gels with a Phosphor Imager (Molecular Dynamics). Fold activation of the test template in die presence of receptor was obtained after correction for recovery and for basal transcription on the ML50 control promoter. Gosed arrows indicate die position of die correctly initiated transcripts. Readdirough transcripts are indicated by open arrows heads. (40) . Subsequently, the extracts were incubated for 1 hour at 30°C in the presence or absence of 0.1/tM dexamethasone and fractionated using mono-Q column chromatography.
Western blot analyses show that vvGR coelutes with HSP90, predominandy in fractions 33 and 34 (-300 mM NaCl) in the absence of hormone ( Fig. 2A) . Incubation of the extract in the presence of 0.1 /iM dexamethasone results in a reduction of the amount of GR in the fractions containing HSP90 and a concomitant appearance of 'free' receptor eluting at around 100 mM NaCl (fractions 22 to 26, Fig. 2B ). Similar results were obtained using the antihormone RU 486 instead of dexamethasone (data not shown). In addition to the two predominant receptor populations, we can detect two minor forms of GR that are not co-eluting with HSP90. They elute at 150-170 mM NaCl (fractions 24-30 in Fig. 2A ) and 350 mM NaCl (detectable as a shoulder in panel A and a distinct peak in panel B), respectively and probably result from mechanical disruption of the HSP90 containing complex during the extraction procedure or during the prolonged incubation at 30 c C. GR, released from the HSP90-containing complex upon incubation with hormone, does not elute from the column at the same salt concentration (peak in 24-25 as compared to 27) suggesting that these two forms of receptor have a different charge and/or conformation. Taken together, the data demonstrate that recombinant GR is largely associated with HSP90 in the cytoplasm of infected cells and that it can be released from the HSP90 complex in a hormone dependent manner.
DNA binding properties of vaccinia expressed GR
The DNA binding properties of wGR and H6-tagged receptors were assessed in mobility shift assays using a double stranded oligonucleotide containing a palindromic GRE. Retarded complexes were obtained with extracts of cells infected with a virus expressing recombinant receptors but not with control wWT extracts (Fig. 3C, lanes 1 to 5) . The relative mobility of the various complexes correlates well with die predicted size of the truncated receptors. The specificity of the GR-GRE interaction was further confirmed by competition experiments ((41) and data not shown).
We next tested whedier the full-length and truncated receptors bind to the palindromic GRE as dimers. Extracts containing H6GRAAB were mixed either with wWT, wGR, H6GR or H6GRAEF extracts and tested in bandshift assays for the formation of complexes with intermediate mobility. Heterodimers between wGR or H6GR with H6GRAAB are readily formed upon mixing of the receptors. Heterodimers involving H6GRAEF are less abundant complexes (see Fig. 3C , lanes 6-9) probably because dimerization is impaired due to deletion of the EFdomain. In line with this explanation is the observation that approximately 5 to 10 times more H6GRAEF as compared to H6GR and H6GRAAB is required to yield equivalent DNA binding and DNAse I footprinting activity (Fig. 3B and data not shown). This is, however, not the case for H6GRmut bearing two point-mutations in the C-terminal EF-domain. In line with the report of Danielian et al. (17) , H6GRmut shows DNA binding and dimerization properties comparable to that of H6GR (Fig. 3D) . However, H6GRmut appears to have a reduced affinity for TA as compared to H6GR (Fig. 1C and E) . Nevertheless, H6GRmut is efficiently translocated from the cytoplasm to the nucleus in response to high concentrations of hormone in recombinant vaccinia virus infected cells (data not shown).
Recombinant GR has transactivating properties in vitro in the absence of ligand
Having established that the biochemical properties of vaccinia expressed GR are similar to those reported for authentic GR, we assessed its transcriptional properties in vitro using different GR responsive promoters. We first used a synthetic promoter, 4GRE.ML, composed of four repeated GREs as present in the enhancer of the rat tyrosine amino transferase gene (35) , linked to the adenovirus major late promoter. Addition of H6GR to a HeLa nuclear extract results in an approximately 10 fold stimulation of the level of transcription as compared to addition of a control fraction derived from a wWT extract (Fig. 4, lanes  1 and 4) . The levels of transcription from a minimal adenovirus major late promoter (ML50) or from a MMTV promoter lacking the GREs (-77MMTV) are not affected by addition of H6GR indicating that the activation observed is GR and GRE-dependent. Specificity of the transcriptional activation was further determined with competitor oligonucleotides. Indeed, only a GRE containing oligonucleotide, but not an unrelated vitamin D3 response element, can efficiendy compete for binding of the receptor resulting in reduced transcriptional activation of the responsive promoter (Fig. 4, compare lanes 2 and 3) .
Tested on the wild type MMTV promoter, H6GR activates less efficiendy the transcription as compared to the synthetic promoter (see Fig. 4, lanes 7 and 8) . This is probably due to the high constitutive level of transcription from the MMTV promoter which contains a CTF/NF1 binding site and CTF/NF-1 proteins are present in HeLa nuclear extracts (data not shown). Point mutations in diis binding site as present in the -231 MMTV.N" promoter result in a strong reduction of the constitutive level of transcription as compared to the wild type MMTV promoter (compare in Fig. 4 , lanes 7 and 8) but do not affect its capacity to respond to GR (Fig. 4, lane 10) . We, therefore, used this mutated MMTV promoter further in this study.
To assess whether hormone governs the transcriptional activity of H6GR, we purified receptors from cytoplasmic extracts incubated with TA, RU 486 or without hormone and compared their ability to transactivate in vitro. Salt-activated H6GR, prepared in the absence of hormone, enhances the level of transcription from the 4GRE.ML and the -231MMTV.N" promoters (10 and 17 fold, respectively, see lanes 2 and 6 in Fig. 5 ). Receptors prepared in the presence of the agonist TA activate the 4GRE.ML promoter 12 fold and the -231 MMTV.N-promoter 10 fold (lane 3 and 7, respectively). With antagonist loaded H6GR, the transcription is activated 10 and 12 fold using 4GRE.ML and -231MMTV.N-(lanes 4 and 8, respectively). These results indicate that the transactivation properties of recombinant GR are independent of the presence of ligand in vitro.
The hormone binding domain has transactivation properties in vitro A possible explanation for this result is that the C-terminal liganddependent transactivation domain does not contribute to a significant extent to the level of transcription in our cell-free assay. We, therefore, assessed the transcriptional activity of Nand C-terminally truncated receptors as well as of a point mutated receptor. The receptors were prepared from nuclear extracts and were loaded with hormone prior to harvesting the cells. We noticed that the levels of transactivation do not differ significandy comparing receptors prepared from nuclear extracts i.e., loaded with hormone in vivo, with receptors prepared from cytosol and activated in vitro (compare for example die corresponding lanes in Fig. 5, 6 and 7) .
We first compared the transcriptional activities of H6GR, H6GRAEF, H6GRAAB and H6GRmut on the 4GRE.ML promoter. Using increasing amounts of each receptor allowed us to determine the maximal activation reached with each receptor. As shown in figure 6 , H6GR enhances the level of transcription about 12 fold from the synthetic promoter (lanes 1-5). Upon deletion of the N-terminal AB-domain (H6GRAAB), the transactivation potential is strongly reduced to less than 20% of that of the full-length receptor (lanes 19-23) . Deletion of the C-terminal EF-domain (H6GRAEF) yields a relatively potent transcriptional activator when tested on the 4GRE.ML promoter Ganes 13-17). We used higher amounts of H6GRAEF as compared to the other receptors in diese experiments in order to compensate for its reduced DNA binding activity. The transactivation properties of H6GRmut are reduced to approximately 50% as compared to full-length receptor. These results indicate that both transactivation domains of GR are functional on a syndietic promoter and suggest that the contribution of the AB-domain (AF1) is somewhat stronger as compared to the contribution of the EF-domain (AF2). Using high amounts of receptor in the cell-free assay, we observe a general repression of the transcription rate (see for example Fig. 6, lane 5) .
Next, we analyzed the transcriptional activation properties of all four receptors using die -231MMTV.N" promoter (Fig. 7) . H6GR efficiently activates diis promoter (lanes 2-6). Interestingly, H6GRmut enhances only weakly die level of transcription of the MMTV.N" promoter in vitro (Fig. 7, lanes  8-12) . More surprisingly, H6GRAEF and H6GRAAB have no significant effect on die level of transcription of this promoter (lanes 13-17 and lanes 19-23, respectively ). These observations indicate that both transactivation domains are required to activate the level of transcription from die MMTV.N" promoter in vitro, suggesting that diey function, in a cooperative manner, on this promoter.
In summary, we conclude diat die hormone binding domain of recombinant H6GR exhibits transcriptional activity in vitro. These transactivation properties are independent of the presence of ligand.
DISCUSSION
Biochemical properties of vaccinia expressed GR
We have presented immunocytochemical evidence diat vaccinia expressed GR is predominandy found in the cytoplasm of recombinant virus infected cells when incubated in the absence of ligand and can be translocated to die nucleus upon addition of ligand. Scatchard analyses have shown that wGR binds TA with equal affinity as endogenous GR from HeLa cells. Following cell fractionation, unliganded wGR is found in the cytoplasmic fraction predominantly in a complex containing HSP90. Incubation of receptor with hormone or anti-hormone on ice results in a partial release of GR from this complex that is further promoted by the addition of NaCl up to 300 mM and/or by elevating the temperature similar to that described previously (16) . We have observed that recombinant receptor activated with salt is able to bind in vitro to DNA in the absence of hormone as previously reported for rat liver GR (26) . Thus, the dissociation of the complex caused by ligand binding in vivo, yielding a DNA binding competent receptor, can be mimicked in vitro without ligand by elevating the salt concentration (44 and our unpublished data). This is remarkable, because the DNA binding capability of the closely related progesterone receptor is dependent on ligand in vitro (45) . The biological significance of this difference and its relation to the distinct intracellular localization of GR and PR in the absence of hormone (cytoplasmic and nuclear, respectively) remains to be established. We conclude from the biochemical characterization that vaccinia expressed GR is comparable with, if not indistinguishable from, authentic GR.
Transactivatlon properties in vitro of vaccinia virus expressed GR Type I receptors contain two independent transactivation domains located in the AB-and EF-regions, termed AFl and AF2, respectively (25) . The transactivation domain in the AB-region has been shown to function in a ligand independent or constitutive manner whereas the activity of the C-terminal transactivation domain is governed by ligand in vivo. The transcriptional activity of the individual domains as well as the cooperativity between both domains has been shown to depend on the cell type, the promoter context in which the hormone responsive element is placed and whether the receptor is loaded with agonist or antagonist (18, 46, 47) .
We have shown in an initial set of experiments that hormone-, anti-hormone or salt-activated receptors are equally active in transactivation from the synthetic 4GRE.ML as well as from the MMTV promoter in vitro. These observations are in agreement with the ligand independent transcriptional activation obtained in vitro using recombinant human GR expressed with the baculovirus system (31) . Using mutated receptors, we have been able to assess the contribution of AFl and AF2 to the level of transcription in vitro. We observed that both transactivation domains of GR are functional on a synthetic promoter. H6GRmut, a full-length receptor with two mutated amino acids in die presumptive C-terminal transactivation domain, allowed us to analyze the contribution of the hormone binding domain to die transcriptional properties of GR without simultaneously inactivating odier functions located within diis domain (except a reduction of its hormone binding affinity). We observed that H6GRmut is less active than the wild type receptor in transactivation of the synthetic 4GRE.ML promoter suggesting that the EF-domain contributes to die overall transcriptional activity of GR on this promoter. Yamamoto and collaborators showed that transcriptional activity of GR on a synthetic promoter is solely determined by the constitutive transactivation domain in die AB-region (19) . Similar results have been described for PR and ER (30, 46) .
Testing die activity of mutated receptors on die MMTV.N" promoter, we show that the hormone binding domain contributes to the transactivation of this promoter. Moreover, our data suggest that AFl and AF2 cooperate to enhance the level of transcription from die MMTV.N" promoter. Similar results were obtained in transient transfection experiments using die MMTV promoter (4 and our unpublished observations). The determinants for die cooperativity between die AB-and EF-domains when bound to the MMTV promoter are under current investigation.
In conclusion, our experiments provide the first in vitro data showing diat the hormone binding domain of GR harbors transactivation properties. Its activity is, in vitro, however not modulated by bound ligand.
Possible implications for the function of GR
The data presented in diis manuscript are in apparent conflict with die model explaining die effects of hormone versus antihormone on die transcriptional activity of GR. Beside dissociation from the HSP90 containing complex, hormone binding is considered to induce a conformational change in die C-terminal domain potentiating its 'ligand dependent' transactivation function. Our results are in agreement widi the fact diat ligand is required to release GR from die HSP90 containing complex. They, however, indicate diat bound ligand does not modulate directiy die transactivation properties of die receptor.
We propose three hypodieses, not necessarily mutually exclusive, to explain why binding of ligand does not affect die transactivation properties of vaccinia virus expressed GR in vitro. Firstiy, our purification procedure involves a treatment of die receptor widi 300 mM NaCl, to release GR from the HSP90 complex; diis might be sufficient to induce a conformational change yielding an active receptor in die absence of hormone. Secondly, die recombinant receptor may be post-translationally modified yielding a transcriptionally active molecule once it is released from die HSP90 containing complex. It has, for example, been shown diat dexameuiasone but not RU 486 induces hyperphosphorylation of GR suggesting diat phosphorylations could determine die transactivation properties of GR (48) . Furthermore, it has been reported diat okadaic acid, a specific phosphatase inhibitor, can induce die activation of die progesterone receptor in die absence of hormone in vivo (49) . Therefore, it is tiiroughout possible tiiat recombinant receptor is constitutively activated due to a vaccinia virus infection related phosphorylation event. Thirdly, ligand binding could affect a property of die receptor diat is required in a step leading to transcriptional activation in vivo, and diat was not reproduced in our in vitro assay. Several studies, using die MMTV promoter as a model, have shown diat GR is involved in altering me nucleosomes at glucocorticoid responsive sites (50, 51) . It has also been reported diat GR induces the formation of hypersensitive sites in die tyrosine amino transferase enhancer, indicative of a change in die nucleosome structure, only in die presence of dexamethasone but not in die presence of RU 486 (52) . One can envision diat die hormone induced conformational change could expose a domain required for nucleosome displacement. The hypodiesis diat die hormone binding domain is direcdy involved in diis activity will be tested in vitro using chromatin reconstituted templates.
